Attendance at religious services, interleukin-6, and other biological parameters of immune function in older adults

International Journal of Psychiatry in Medicine

Volumn 27, Issue 3, 1997, Pages 233-250

  Koenig, Harold G ^a   Cohen, Harvey Jay ^a   George, Linda K ^a   Hays, Judith C ^a   Larson, David B ^a   Blazer, Dan G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biological; Depression; Hearth; Immune system; Religion; Spirituality; Stress

Indexed keywords

ALPHA 2 GLOBULIN; D DIMER; FIBRIN DERIVATIVE; INTERLEUKIN 6;

AGED; DEPRESSION; FEMALE; HUMAN; IMMUNE STATUS; IMMUNITY; LIFE EVENT; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; RELIGION; REVIEW; SOCIAL ASPECT; STATISTICAL ANALYSIS;

EID: 0030667465     PISSN: 00912174     EISSN: None     Source Type: Journal    
DOI: 10.2190/40NF-Q9Y2-0GG7-4WH6     Document Type: Review

References (56)

1. Koenig HG, Futterman A. Religion and health outcomes: A review and synthesis of the literature. Background paper, published in proceedings of Conference on Methodological Approaches to the Study of Religion, Aging, and Health, sponsored by the National Institute on Aging (3/16-3/17), 1995.
2. Koenig HG. Research on religion and aging. NY: Greenwood Press, 1995.
3. Koenig HG. Is religion good for your health? NY: Haworth Press, 1997.
4. Graham TW, Kaplan BH, Cornoni-Huntley JC, James SA, Becker C, Hames CG, Heyden S. Frequency of church attendance and blood pressure elevation. Journal of Behavioral Medicine 1978;1(1):37-43.
5. Larson DB, Koenig HG, Kaplan BH, Greenberg RS, Logue E, Tyroler HA. The impact of religion on men's blood pressure. Journal of Religion and Health 1989;28:265-278.
6. Livingston IL, Levine DM, Moore RD. Social integration and black intraracial variation in blood pressure. Ethnicity & Disease 1991;1:135-149.
7. Colantonio A, Kasl SV, Ostfeld AM. Depressive symptoms and other psychosocial factors as predictors of stroke in the elderly. American Journal of Epidemiology 1992;136:884-894.
8. Comstock GW, Partridge KB. Church attendance and health. Journal of Chronic Disease 1972;25:665-672.
9. Strawbridge WJ, Cohen RD, Shema SJ, Kaplan GA. Frequent attendance at religious services and mortality over 28 years. American Journal of Public Health, 1997; 87:957-961.
10. McCullough ME, Larson DB, Koenig HG, Milano MG. Systematic review of published research on religious commitment and mortality (1967-1996). Journal of the American Medical Association, in submission.
11. Levin JS, Markides KS. Religious attendance and subjective health. Journal for the Scientific Study of Religion 1986;25:31-40.
12. Idler EL, Kasl SV. Religion, disability, depression, and the timing of death. American Journal of Sociology 1992;97:1052-1079.
13. Idler EL, Kasl SV. Religion among disabled and nondisabled elderly persons: Attendance at religious services as a predictor of the course of disability. Journal of Gerontology, in press.
14. Ellison CG, George LK. Religious involvement, social ties, and social support in a Southeastern community. Journal for the Scientific Study of Religion 1994; 33:46-61.
15. George LK. Social and economic factors related to psychiatric disorders in late life. In: Busse EW, Blazer DG editors. Geriatric psychiatry. 2nd Edition. Washington, DC: American Psychiatric Press, 1996.
16. Koenig HG, George LK, Siegler I. The use of religion and other emotion-regulating coping strategies among older adults. Gerontologist 1988;28:303-310.
17. Pressman P, Lyons JS, Larson DB, Strain JS. Religious belief, depression, and ambulation status in elderly women with broken hips. American Journal of Psychiatry 1990;147:758-760.
18. Koenig HG, Cohen HJ, Blazer DG, Pieper C, Meador KG, Shelp F, Goli V, DiPasquale R. Religious coping and depression in elderly hospitalized medically ill men. American Journal of Psychiatry 1992;149:1693-1700.
19. Kennedy GJ, Kelman HR, Thomas C, Chen J. Religious affiliation, practice and depression among 1855 older community residents. Journal of Gerontology 1996; 51B:P301-P308.
20. Kendler KS, Gardner CO, Prescott CA. Religion, psychopathology, and substance use and abuse. American Journal of Psychiatry 1997;154:322-329.
21. Koenig HG, Hays JC, George LK, Blazer DG. Modeling the cross-sectional relationships between religion, physical health, social support, and depressive symptoms. American Journal of Geriatric Psychiatry 1997;5:131-143.
22. Ader R. Psychoneuroimmunology. NY: Academic Press, 1981.
23. Irwin M, Patterson T, Smith TL, Caldwell C, Brown SA, Gillin C, Grant I. Reduction of immune function in life stress and depression. Biological Psychiatry 1990; 27:22-30.
24. Lesserman J, Petitto JM, Perkins DO, Folds JD, Golden RN, Evans DL. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men: A 2-year follow-up study. Archives of General Psychiatry 1997;54:297-285.
25. Van Snick J. Interleukin-6: An overview. Annual Review of Immunology 1990;8:253-278.
26. Hirano T. The biology of interleukin-6. Molecular Biology and Immunology 1992; 51:153-180.
27. Ershler WB. Interleukin-6: A cytokine for gerontologists. Journal of the American Geriatrics Society 1993;41:176-181.
28. Beutler B. A proinflammatory mediator with potential relevance in aging. Journal of the American Geriatrics Society 1990;38:1027-1036.
29. Pattengale PK, Firth CH. Contributions of recent research to the classification of spontaneous lymphoic cell neoplasms in mice. CRC Critical Review of Toxicology 1986;16:185-212.
30. Emilie D, Wijdenes J, Gisselbrecht C, Jarrouse B, Billaud E, Blay JY, Gabarre J, Gaillard JP, Brochler J, Raphael M. Administration of anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: Effect on lymphoma growth and on B clinical symptoms. Blood 1994; 84:2472-2479.
31. Ershler WB, Sun WH, Binkley N. The role of interleukin-6 in certain age-related diseases. Drugs & Aging 1994;5:358-365.
32. Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunology Review 1992;127:25-50.
33. Abraham CR, Shirahama T, Potter H. Alpha 1 antichymotrypsin is associated solely with amyloid deposits containing the B protein. Amyloid and cell localization of alphal-antichymotripsin. Neurobiology of Aging 1990;11:123-129.
34. Vandenabeele P, Fiers W. Is amyloidogenesis during Alzheimer's disease due to an IL-1/IL-6 mediated "acute phase response" in the brain? Immunology Today 1991; 12:217-219.
35. Ishimi Y, Miyaura C, Jin CHY, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, et al. IL-6 is produced by osteoblasts and induces bone resorption. Journal of Immunology 1990;145:3297-3303.
36. Roodman GD. Interleukin-6: An osteoporotic factor? Journal of Bone Miner Research 1992;7:475-478.
37. Cohen HJ, Pieper CF, Harris T, Rao KMK, Currie MS. The association of plasma IL-6 levels with functional disability in community dwelling elderly. Journal of Gerontology (Medical Sciences), 1997;52A:M201-M208.
38. Ullum H, Diamant M, Victor J, Gotzsche PC, Bendtzen K, Skinhoj P, Pedersen BK. Increased circulating levels of interleukin-6 in HIV-seropositive subjects. Journal of Acquired Immune Deficiency Syndrome and Human Retroviroloogy 1996; 13:93-94.
39. de Wit R, Raasveld MH, ten Berge RJ, van der Wouw PA, Bakker PJ, Veenhof CH. Interleukin-6 concentrations in the serum of patients with AIDS-associated Kaposi's sarcoma during treatment with interferon-alpha. Journal of Internal Medicine 1991;229:539-542.
40. Bianci M, Sacerdote P, Locatelli L, Mantegazza P, Panerai AE. Corticotropin releasing hormone, interleukin-1 alpha, and tumor necrosis factor share characteristics of stress mediators. Brain Research 1991;546:139-142.
41. Seidel A, Arolt V, Huntstiger M, Rink L, Behnisch A, Kirchner H. Cytokine production and serum proteins in depression. Scandinavian Journal of Immunology 1994; 41:534-538.
42. Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P. Relationships between interleukin-6 activity, acute phase proteins and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatric Research 1993; 49:11-27.
43. Maes M, Meltzer HY, Buckley P, Bosmans E. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression. European Archives of Psychiatric & Clinical Neurosciences 1995;244:325-329.
44. Watanobe H, Takebe K. Intravenous administration of tumor necrosis factor-alpha stimulates corticotropin releasing hormone secretion in the push-pull cannulated median eminence of freely moving rats. Neuropeptides 1992;22:81-84.
45. Naitoh Y, Fukata J, Tominaga T, et al. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochemical & Biophysical Researc Comm 1988;155:1459-1463.
46. Bernardini R, Kamilaris TC, Calogero AE, Johnson EO, Gomez MT, Gold PW, Chrousos GP. Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology 1990;126:1876-2881.
47. Coroni-Huntley J, Ostfeld AM, Taylor JO, Wallace RB, Blazer D, Berkman LF, Evans DA, Kohout FJ, Lemke JH, Scherr PA, et al. Established populations for epidemiologic studies of the elderly: Study design & methodology. Aging and Clinical Experimental Research 1993;5:27-37.
48. Blazer DG, Burchett BM, Service C, George LK. The association of age and depression among the elderly: An epidemiologic exploration. Journal of Gerontology 1991; 46:M210-M215.
49. Katz S, Akpom CA. A measure of primary sociobiological functions. International Journal of Health Service 1976;6:493-507.
50. Rosow I, Breslau N. A Guttman health scale for the aged. Journal of Gerontology 1996;21:556-559.
51. Fillenbaum GG. Screening the elderly: A brief instrumental ADL measure. Journal of the American Geriatrics Society 1985;33:698-706.
52. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychiatric Measures 1977;1:385-401.
53. Package Insert, Quantikine, R & D Systems, Minneapolis, MN.
54. Rao KMK, Pieper CS, Currie MS, Cohen HJ. Variability of plasma IL-6 and cross-linked fibrin dimers over time in community dwelling elderly subjects. American Journal of Clinical Pathology 1994;102:802-805.
55. Ur E, White PD, Brossman A. Hypothesis: Cytokines may be activated to cause depressive illness and chronic fatigue syndrome. European Archives of Psychiatry and Clinical Neurosciences 1992;241:317-322.
56. Borish L, Rosenvasser LJ. Update on cytokines. Journal of Allergy and Clinical Immunology 1996;97:719-734.